XML 54 R26.htm IDEA: XBRL DOCUMENT v3.20.1
Derivative Instruments (Tables)
3 Months Ended
Mar. 31, 2020
Summary of Derivative Instruments [Abstract]  
Summary Of The Effect Of Derivative Instruments On The Consolidated Statements Of Changes In Equity And Income
Below is a summary of the effect of derivative instruments on the consolidated statements of changes in equity and income for the three months ended March 31, 2020 and 2019.
Effect of Derivative Instruments on the Consolidated Statements of Changes in Equity and Comprehensive Income for the Three Months Ended March 31, 2020 and 2019
(Dollars in thousands)
 
Three Months Ended March 31,
 
Description
2020
 
2019
 
Cash Flow Hedges
 
 
 
 
Interest Rate Swaps
 
 
 
 
Amount of Loss Recognized in AOCI on Derivative
$
(10,642
)
 
$
(2,439
)
 
Amount of (Expense) Income Reclassified from AOCI into Earnings (1)
(465
)
 
775

 
Cross-Currency Swaps
 
 
 
 
Amount of Gain (Loss) Recognized in AOCI on Derivative
1,139

 
(311
)
 
Amount of Income Reclassified from AOCI into Earnings (2)
206

 
134

 
 
 
 
 
 
Net Investment Hedges
 
 
 
 
Cross-Currency Swaps
 
 
 
 
Amount of Gain (Loss) Recognized in AOCI on Derivative
13,175

 
(3,839
)
 
Amount of Income Recognized in Earnings (2) (3)
162

 
138

 
 
 
 
 
 
Total
 
 
 
 
Amount of Gain (Loss) Recognized in AOCI on Derivatives
$
3,672

 
$
(6,589
)
 
Amount of (Expense) Income Reclassified from AOCI into Earnings
(259
)
 
909

 
Amount of Income Recognized in Earnings
162

 
138

 
 
 
 
 
 
Interest expense, net in accompanying consolidated statements of income and comprehensive income
$
34,753

 
$
33,963

 
Other income in accompanying consolidated statements of income and comprehensive income
$
7,573

 
$
344

 
(1) Included in "Interest expense, net" in the accompanying consolidated statements of income and comprehensive income for the three months ended March 31, 2020 and 2019.
(2) Included in "Other income" in the accompanying consolidated statements of income and comprehensive income for the three months ended March 31, 2020 and 2019.
(3) Amounts represent derivative gains excluded from the effectiveness testing.